COMMUNIQUÉS West-GlobeNewswire

-
SeeThruEquity Upgrades RXMD Price Target to $0.35 per Share
09/03/2018 -
SuperSonic Imagine to Showcase Aixplorer® Ultimate at 28th Annual Interdisciplinary Breast Center Conference
09/03/2018 -
Clover Health Discusses Behavioral Science at SXSW 2018
09/03/2018 -
ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update
09/03/2018 -
Innovations with Ed Begley Jr. to Feature Canada House’s Evidence-Based Cannabis Products & Services on Fox Business Innovations TV Series
09/03/2018 -
Galectin Therapeutics to Present at Two International Conferences in March
09/03/2018 -
EyeGate Pharma To Participate At The 30TH Annual ROTH Conference
09/03/2018 -
First Choice Healthcare Solutions Announces Appointment of Sheila Schweitzer to Board of Directors and Retirement of Donald Bittar
09/03/2018 -
Scythian Biosciences Corp. Announces Results of Special Meeting of Shareholders and Grant of Options and DSUs
09/03/2018 -
Teladoc to Participate in Upcoming Investor Conferences
09/03/2018 -
Crown Bioscience to Showcase Scientific Expertise at Cambridge UK Symposium: Preclinical Evaluation of Novel Immunotherapies
09/03/2018 -
Aclaris Therapeutics Announces Issuance of U.S. Patent Covering a JAK Inhibitor for Treating Hair Loss Disorders
09/03/2018 -
Vericel to Present at BioCentury’s 25th Annual Future Leaders in the Biotech Industry Conference
09/03/2018 -
Exalenz Bioscience to Participate in Upcoming Investor Conferences
09/03/2018 -
Stealth Mark Joins the Industry Council for Tangible Assets and its Anti-Counterfeiting Task Force
09/03/2018 -
Arch Biopartners Closes $1.25M Non-Brokered Private Placement Financing
09/03/2018 -
VBL Therapeutics to Report Fiscal 2017 Results on March 15
09/03/2018 -
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
09/03/2018 -
Projecting a Per Share Price Target of $1.25, PotNetwork Holding Inc. Highlighted as “Strong Speculative Buy” in Research Initiated by Harbinger Research, LLC
09/03/2018
Pages